|
|||||
|
|
MiR-503 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R and BCL2 |
|
| Authors: | Wang Tongshan, Ge Gaoxia, Ding Yin, Zhou Xin, Huang Zebo, Zhu Wei, Shu Yongqian, Liu Ping |
| Affiliation: | [1]Department of Oncology First Affiliated Hospital of Nanjing Medical University,Nanjing,Jiangsu 210029,China; [2]Department of Clinical Laboratory First Affiliated Hospital of Nanjing Medical University,Nanjing,Jiangsu 210029,China; [3]State Key Laboratory of Analytical Chemistry for Life Science,School of Chemistry and Chemical Engineering,Nanjing University,Nanjing,Jiangsu 210093,China; [4]Department of Oncology,Jiangsu Province Hospital,Nanjing,Jiangsu 210029,China |
| Abstract: | miR-503 cisplatin resistance insulin-like growth factor-1 receptor B-cell lymphoma 2 gastric cancer |
| Keywords: | miR-503 cisplatin resistance insulin-like growth factor-1 receptor B-cell lymphoma 2 gastric cancer |
| 本文献已被 维普 等数据库收录！ | |
| 点击此处可从《中华医学杂志(英文版)》浏览原始摘要信息 | |
| 点击此处可从《中华医学杂志(英文版)》下载全文 | |